ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,469.30
0.39%
Dow Jones
39,112.16
-0.76%
US Dollar vs MXN
18.10425
-0.12%
Brent Oil
84.65
0.55%
Bitcoin
61,624.27
-0.30%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Adaptive Biotechnologies Corporation (ADPT)

  7. Adaptive Biotechnologies Corporation (ADPT) Noticias

ADPT Adaptive Biotechnologies Corporation

3.42
0.13 (3.95%)
25 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Adaptive Biotechnologies Corporation ADPT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.13 3.95% 3.42 18:31:17
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.31 3.265 3.425 3.39 3.29
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
11/6/202415:15EDGAR2Form 8-K - Current report
31/5/202406:30GLOBEAdaptive Biotechnologies Announces Data Supporting the..
29/5/202415:05GLOBEAdaptive Biotechnologies to Participate in the Goldman Sachs..
24/5/202411:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
17/5/202417:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202415:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202415:15EDGAR2Form 8-K - Current report
07/5/202415:05GLOBEAdaptive Biotechnologies Reports First Quarter 2024..
17/4/202415:05GLOBEAdaptive Biotechnologies to Report First Quarter 2024..
02/4/202415:05GLOBEAdaptive Biotechnologies Provides Strategic Review Update..
27/3/202407:30GLOBEAdaptive Biotechnologies to Hold a Business Update..
06/3/202418:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202418:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202418:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202418:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202418:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202418:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202418:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202418:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202418:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202418:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202418:38EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/2/202415:05GLOBEAdaptive Biotechnologies to Present at the TD Cowen 44th..
14/2/202415:15EDGAR2Form 8-K - Current report
14/2/202415:05GLOBEAdaptive Biotechnologies Reports Fourth Quarter and Full..
29/1/202415:05GLOBEAdaptive Biotechnologies to Report Fourth Quarter and Full..
29/1/202415:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
27/12/202315:05GLOBEAdaptive Biotechnologies to Present at the 42nd Annual J.P...
09/12/202307:30GLOBEAdaptive Biotechnologies Announces New Data Highlighting the..
05/12/202306:30GLOBEAdaptive Biotechnologies and Collaborators to Present More..
20/11/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202315:15EDGAR2Form 8-K - Current report
09/11/202315:05GLOBEAdaptive Biotechnologies Reports Third Quarter 2023..
07/11/202306:30GLOBEAdaptive Biotechnologies Announces New Translational..
02/11/202315:05GLOBEAdaptive Biotechnologies to Report Third Quarter Financial..
13/9/202306:30GLOBEAdaptive Announces Launch of Epic Integration for clonoSEQ®
01/9/202316:16EDGAR2Form 8-K - Current report
30/8/202315:30GLOBEAdaptive Biotechnologies to Participate in the Morgan..
08/8/202316:26EDGAR2Form 144 - Report of proposed sale of securities
08/8/202315:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202315:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202315:17EDGAR2Form 8-K - Current report
02/8/202315:05GLOBEAdaptive Biotechnologies Reports Second Quarter 2023..
10/7/202315:05GLOBEAdaptive Biotechnologies to Report Second Quarter Financial..
03/7/202314:14EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
ADPT
Adaptive Biotechnologies
BOV
ITUBS403
ITUBS403 Ex:38,74
BIT
I04641
Banca IMI
LSE
0QKD
Forbo
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados